Dynamic reversibility of α‐synuclein serine‐129 phosphorylation is impaired in synucleinopathy models
The EMBO Reports · 2023
DOI: 10.15252/embr.202357145 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Reports, 2023. Verfasst von Nagendran Ramalingam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Synucleinopathies, Parkinson Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIA NIH HHS, HHS | NIH | National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Nagendran Ramalingam, Dennis J Selkoe, Ulf Dettmer
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- HHS | NIH | National Institute of Neurological Disorders and Stroke
- HHS | NIH | National Institute on Aging
Zitieren
APA
Ramalingam, N., Brontesi, L., Jin, S. X., Selkoe, D. J., & Dettmer, U. (2023). Dynamic reversibility of α‐synuclein serine‐129 phosphorylation is impaired in synucleinopathy models. The EMBO Reports. https://doi.org/10.15252/embr.202357145
Vancouver
Ramalingam N, Brontesi L, Jin SX, Selkoe DJ, Dettmer U. Dynamic reversibility of α‐synuclein serine‐129 phosphorylation is impaired in synucleinopathy models. The EMBO Reports. 2023. doi:10.15252/embr.202357145
BibTeX
@article{Ramalingam2023,
author = {Ramalingam, Nagendran and Brontesi, Lisa and Jin, Shan-Xue and Selkoe, Dennis J and Dettmer, Ulf},
title = {Dynamic reversibility of α‐synuclein serine‐129 phosphorylation is impaired in synucleinopathy models},
journal = {The EMBO Reports},
year = {2023},
doi = {10.15252/embr.202357145}
}
EUVIMED